We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
Arrowstreet Capital
76
Arrowstreet Capital
Massachusetts
$81.2M -$133M -2,654,260 -63%
AI
77
Analytic Investors
California
$80.1M +$1.62M +32,330 +2%
HSBC Holdings
78
HSBC Holdings
United Kingdom
$79.2M -$5.24M -104,682 -6%
BJ
79
BlackRock Japan
Japan
$78.6M +$751K +14,997 +1%
MTB
80
Mizuho Trust & Banking
Japan
$77.3M -$15.6M -311,950 -17%
PPA
81
Parametric Portfolio Associates
Washington
$76.4M -$2.81M -56,134 -4%
HCM
82
Huber Capital Management
California
$75.8M +$18.5M +369,400 +33%
RFC
83
Russell Frank Company
Washington
$69.1M -$1.39M -27,855 -2%
SC
84
Saturna Capital
Washington
$65.5M -$10K -200 -0%
N
85
Natixis
France
$64.4M -$5.41M -107,991 -8%
WI
86
WBI Investments
New Jersey
$63.3M +$35.1M +700,095 +129%
CIC
87
Crawford Investment Counsel
Georgia
$62.1M +$911K +18,183 +2%
EVM
88
Eaton Vance Management
Massachusetts
$60.4M -$3.64M -72,595 -6%
Principal Financial Group
89
Principal Financial Group
Iowa
$58.9M -$132M -2,630,004 -70%
WCM
90
Winton Capital Management
United Kingdom
$57.1M +$11.7M +232,719 +26%
First Trust Advisors
91
First Trust Advisors
Illinois
$55.5M +$8.09M +161,502 +17%
ARC
92
Absolute Return Capital
Massachusetts
$54.3M -$9.57M -191,090 -15%
GC
93
Guggenheim Capital
Illinois
$53.9M +$91.7K +1,832 +0.2%
Bank of Montreal
94
Bank of Montreal
Ontario, Canada
$52M -$31.9M -636,687 -38%
TD Asset Management
95
TD Asset Management
Ontario, Canada
$51.4M +$1.67M +33,446 +3%
Dimensional Fund Advisors
96
Dimensional Fund Advisors
Texas
$51M -$302K -6,027 -0.6%
PP
97
Prudential plc
United Kingdom
$50.7M -$44.2M -882,923 -47%
GIA
98
Gateway Investment Advisers
Ohio
$47.4M -$256K -5,116 -0.5%
Adage Capital Partners
99
Adage Capital Partners
Massachusetts
$47.1M -$15M -300,000 -24%
SG Americas Securities
100
SG Americas Securities
New York
$46.9M -$4.06M -80,983 -8%

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.